Hemodynamic Monitoring Sensor System is minimally invasive.
January 21, 2013 -
Used with existing arterial catheter and connected to Edwards Lifesciences Vigileo® monitor, CardioFlo™ provides accurate, reliable hemodynamic monitoring data. System facilitates real-time assessment of hemodynamic and cardiovascular status, helping guide clinical decision-making and effective management of critically ill patients. In clinical testing, agreement between hemodynamic data provided by Edwards Lifesciences FloTrac and the ICU Medical CardioFlo sensor systems was within 1%.
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
|Original Press Release |
ICU Medical, Inc.
951 Calle Amanecer
San Clemente, CA, 92673
ICU Medical Launches CardioFlo(TM) Minimally Invasive Hemodynamic Monitoring Sensor System
Shown in clinical testing to provide accurate, reliable, and cost-effective hemodynamic monitoring, CardioFlo will be introduced at the Society of Critical Care Medicine (SCCM) Critical Care Congress in San Juan, Puerto Rico
SAN CLEMENTE, Calif. -- ICU Medical, Inc. (Nasdaq: ICUI) today announced it will launch the CardioFlo hemodynamic monitoring sensor system at the Society of Critical Care Medicine (SCCM) Critical Care Congress in San Juan, Puerto Rico, January 19-23, 2013. CardioFlo is a minimally invasive hemodynamic monitoring sensor system that, when used with an existing arterial catheter and connected to an Edwards Lifesciences Vigileo(®) monitor, provides accurate and reliable hemodynamic monitoring data and an average of 40% cost savings over the Edwards Lifesciences FloTrac(®) sensor.
CardioFlo facilitates the real-time assessment of hemodynamic and cardiovascular status, helping guide clinical decision-making and effective management of critically ill patients. In clinical testing, the level of agreement between the hemodynamic data provided by the Edwards Lifesciences FloTrac and the ICU Medical CardioFlo sensor systems was within one percent. As a result, CardioFlo provides a cost-effective alternative to the FloTrac sensor without sacrificing accuracy or reliability.
ICU Medical's proven hemodynamic monitoring technology has been providing clinicians with accurate and reliable measurements for more than 30 years. As part of ICU Medical's Critical Care product line, CardioFlo is available with the SafeSet closed blood sampling system, which allows clinicians to reduce blood discard waste during diagnostic phlebotomy by reinfusing it to the patient. The launch of CardioFlo reflects ICU Medical's commitment helping clinicians increase clinical and economic efficiencies by delivering accuracy and reliability while decreasing costs.
Contact: Tom McCall
Vice President, Marketing
About ICU Medical, Inc.: ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. The company's complete product line includes custom IV systems, closed delivery systems for hazardous drugs, needlefree IV connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
*The FloTrac and Vigileo trademarks are owned by Edwards Lifesciences and not ICU Medical. ICU Medical does not manufacture or sell either the FloTrac Sensor or Vigileo Monitor.